Resource Library
Showing 81 to 90 of 324 results
Maura C. had recently returned to work after maternity leave when her daughter, then 15 months old, was diagnosed with acute myeloid leukemia (AML) and immediately admitted to the oncology ward. “This is a nightmare I’m not waking up from,” Maura thought over the 5 months her toddler was in the hospital. She says she and her husband moved from their initial…
Tziona Lugasi, clinical psychologist in the hemato-oncology department at CHU Sainte-Justine, talks about the impact of cancer on children, teens and their parents, and the transition from pediatric care to adult health care.
It may be the first time you've talked about your blood cancer, since your diagnosis, with anyone outside immediate family, or it may be after years of living with cancer... Either way, the LLSC community services lead in your region is ready to listen and support you in any way you need. Geoffrey Molle, one of those leads, talks about the confidential…
Graft vs Host Disease, known as GvHD, is a side effect of a life saving procedure. People who undergo an allogeneic stem cell transplant - when a donor's stem cells are transplanted into the recipient - can experience either acute or chronic GvHD. In this podcast, listen to blood cancer survivor Libby Goszer, who describes her experience living with…
Scientists continue to gain a deeper understanding of the genetic changes that lead to the development of cancers. This knowledge is being used to develop more precise treatments for blood cancers, especially in Acute Myeloid Leukemia (AML).
In this webcast, Dr. Aly Karsan talked about the latest research developments in precision medicine…
In this webcast, Dr. Aly Karsan talked about the latest research developments in precision medicine…
In this presentation, Dr. John Dick, one of Canada’s pioneering scientists in the field of “cancer stem cells”, will explain how his research into the causes of blood cancers holds the promise for improved treatments and quality of life for Canadians affected by blood cancers.
In this "Innovation in Research" webcast recording, you will learn about the community of microbes (bacteria, fungi, viruses and their genes) living within our digestive tracts, known as the “gut microbiome,” and how it can play a role in blood cancer treatment and quality of life.
RNA is more than just DNA's lesser-known cousin. Dr. Katherine Borden, Professor, Pathology, Cell Biology at the Institute for Research in Immunology and Cancer, University of Montreal and Dr. Sarit Assouline, chief of the Division of Hematology at the JGH and Senior Investigator in the Lady Davis Institute at the JGH, unpack the scientific wonder that…
In this 2025 webcast, four scientists funded by the LLSC's AI Catalyst Grant talk about their work investigating how AI / machine learning can speed up discovery and detection of blood cancers in their research work. Moderated by Dr. Paul O'Connell, LLSC Research Program Director.
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.